Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Tokenized Asset Market Hits $349.2B as Ethereum Dominates

Tokenized Asset Market Hits $349.2B as Ethereum Dominates

CoinpediaCoinpedia2026/10/05 13:09
Story Highlights
  • The tokenized asset market stands at $349.2B across 50 tracked blockchains.

  • Ethereum and Tron control 80.2% of the total market.

  • Arc, Tempo and HyperEVM recorded the largest 30-day gains.

The tokenized asset market has reached $349.2 billion across 50 tracked blockchains, but the headline number hides a striking concentration problem. Ethereum and Tron alone control 80.2% of the market, leaving everyone else fighting over a much smaller slice.

Ethereum And Tron Still Control Most Capital

Solana holds 5.2% at $18.2 billion, while BNB Chain accounts for 2.6%. HyperEVM, Base and Arbitrum One follow with 2%, 1.5% and 1.3%, respectively. So much for a neatly distributed multichain market.

Tokenized Asset Market Hits $349.2B as Ethereum Dominates image 0

Tokenized Assets Show Adoption Beyond Market Cap

There is, however, more happening underneath the headline valuation. The number of holders has reached 315.5 million, rising 3.3% over 30 days and 11.2% over 90 days.

Tokenized Asset Market Hits $349.2B as Ethereum Dominates image 1

DeFi activity also looks considerably healthier than the overall market-cap growth. The $28.7 billion locked in DeFi represents 8.2% of total tokenized assets, with TVL up 7.8% over 30 days and 26.7% over 90 days.

Meanwhile, the $3.5 billion in 24-hour DEX volume tells a different story. Trading volume has fallen 58.2% over 30 days and 28.4% over 90 days.

Smaller Chains Are Quietly Adding New Capital

The most interesting numbers may be coming from the smaller networks. Arc added $508.3 million over 30 days, followed by Tempo at $501 million and HyperEVM at $500.5 million. That doesn’t overturn Ethereum’s dominance. Not even close.

But it does show where fresh capital is appearing within the tokenized asset market. Ethereum remains the giant, while newer execution environments are posting notable short-term expansion.

News Image 0News Image 1
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Third Life World signs deal to buy voting control of Transglobal Management Group

Third Life World signed a definitive control share purchase agreement to take voting control of Transglobal Management Group (TMGI). The deal transfers a Series A Preferred control block holding a majority of voting rights to Third Life World. TMGI plans to make Third Life World’s AI-agent virtual world platform its core operating business. TMGI will create new Series B Preferred Stock to support the purchase; closing remains subject to customary conditions. At closing, controlling shareholder Marc Angell will resign his officer roles and stay on as a consultant during the transition. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transglobal Management Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081100PRIMZONEFULLFEED9842281) on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/08 15:00

BUZZ-CSL plans to convert all its plasma centers in the US to use Haemonetics equipment, driving the company's stock price to soar

October 8 – ** Shares of medical device manufacturer Haemonetics (HAE.N) surged nearly 16% to $117.81 ** The stock hit an intraday high of $120.61, marking its highest level since early 2021 ** The company stated that CSL Plasma, a subsidiary of Australia’s CSL Group (CSL.AX), expects to transition all its U.S. plasma collection centers to using HAE’s NexSys devices and kits by the end of 2027 ** CSL has also terminated its agreement with HAE rival Terumo (Terumo 4543.T) – according to BTIG ** This transition will help HAE win back business lost since 2021, when its largest plasma client CSL announced it would not renew its U.S. supply contract ** BTIG estimates that, based on approximately $155 million in revenue HAE generated from CSL’s U.S. business in fiscal year 2024, this account could add about $0.60 per share to adjusted earnings annually, though it notes that actual revenue and profit margins remain unclear ** The brokerage maintained its “Buy” rating and raised its price target from $110 to $130, stating that the deal alleviates market share loss concerns and boosts sales growth prospects ** Including today’s gains, the stock is up 49.46% so far this year (For the convenience of non-English speakers, Reuters provides its reports in several other languages through automated translation. Because automated translation may be inaccurate or lack needed context, Reuters does not guarantee the accuracy of the automated text, which is offered purely as a reader service. Reuters accepts no liability for any damage or loss caused by the use of automated translation services.)

路透社•2026/10/08 14:36